These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6862789)

  • 21. Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events.
    Lowe GD; Rumley A
    Thromb Haemost; 1999 Aug; 82(2):667-72. PubMed ID: 10605766
    [No Abstract]   [Full Text] [Related]  

  • 22. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
    Chek JB; Panchenko NI
    East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of soluble fibrin monomer complexes in blood by means of protamine sulphate test.
    Lipiński B; Worowski K
    Thromb Diath Haemorrh; 1968 Nov; 20(1):44-9. PubMed ID: 4236938
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong.
    Chan JC; Kwok MM; Cockram CS; Prematilleke MN; Tomlinson B; Critchley JA
    Singapore Med J; 1993 Apr; 34(2):145-7. PubMed ID: 8266156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical pathology of heartwater. III. Changes in blood clotting, blood calcium, blood protein, haematocrit and white-cell counts in sheep with experimentally induced heartwater.
    Van Amstel SR; Reyers F; Myburgh E; Pretorius G; Sacks P
    Onderstepoort J Vet Res; 1994 Mar; 61(1):21-7. PubMed ID: 7898894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of fibrinogen in protamine-induced pulmonary hypertension.
    Sogawa M; Mohammad SF
    J Surg Res; 1997 Nov; 73(1):80-4. PubMed ID: 9441797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of soluble fibrin by turbidimetry of its protamine sulphate-induced paracoagulation.
    Wieding JU; Eisinger G; Köstering H
    J Clin Chem Clin Biochem; 1989 Feb; 27(2):57-63. PubMed ID: 2746164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The fibrinogen degradation products (FgDP) levels in liver disease.
    Song KS; Kim HS; Park KE; Kwon OH
    Yonsei Med J; 1993 Sep; 34(3):234-8. PubMed ID: 8259700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggregation of fibrinogen and its degradation products by basic proteins. An electron microscope study.
    Stewart GJ; Niewiarowski S
    Thromb Diath Haemorrh; 1971 Jun; 25(3):566-79. PubMed ID: 5105492
    [No Abstract]   [Full Text] [Related]  

  • 31. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
    Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
    Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation abnormalities in dogs with neoplastic disease.
    Madewall BR; Feldman BF; O'Neill S
    Thromb Haemost; 1980 Aug; 44(1):35-8. PubMed ID: 6893502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Protaminase activity of plasma and serum in vitro. II.- Electrophoretic study of serum albumin-protamine soluble complexes].
    Blass J; Verriest C; Vicaigne MB; Detruit H; Weiss M
    Pathol Biol (Paris); 1984 Jan; 32(1):40-4. PubMed ID: 6701006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased amount of arginine in plasma clot after administration of protamine to dogs.
    Farbiszewski R; Worowski K; Glowiński S
    Bull Acad Pol Sci Biol; 1974; 22(7-8):435-7. PubMed ID: 4429849
    [No Abstract]   [Full Text] [Related]  

  • 37. Crystal structures of fragments D and double-D from fibrinogen and fibrin.
    Doolittle RF; Spraggon G; Everse SJ
    Thromb Haemost; 1999 Aug; 82(2):271-6. PubMed ID: 10605713
    [No Abstract]   [Full Text] [Related]  

  • 38. Is there any effect of tumor burden on hemostatic parameters in cancer patients? A case-control study of hemostatic abnormalities and anticardiolipin antibodies in solid tumors.
    Turna H; Ozguroglu M; Bolayirli M; Orhanoglu T; Balci H
    Clin Appl Thromb Hemost; 2009; 15(4):454-7. PubMed ID: 18160567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3.
    Gonias SL; Pasqua JJ; Greenberg C; Pizzo SV
    Thromb Res; 1985 Jul; 39(1):97-116. PubMed ID: 4035652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet adhesion to fibrinogen, fibrin monomer, and fibrin protofibrils in flowing blood -- the effect of fibrinogen immobilization and fibrin formation.
    Jirousková M; Dyr JE; Suttnar J; Holada K; Trnková B
    Thromb Haemost; 1997 Sep; 78(3):1125-31. PubMed ID: 9308765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.